BHC241115P12500
- 0.00
- 0.000.00%
Bausch Health Newsroom
Express News | Icahn Enterprises Discloses 9% Ownership Stake in Bausch Health Companies as of Sept 30 - Presentation
Alembic Pharmaceuticals Gets Final US FDA Nod for Diltiazem Hydrochloride Capsules
Bausch Health Companies Inc.'s (NYSE:BHC) Path To Profitability
Why Bausch Health (BHC) Is a Top Momentum Stock for the Long-Term
Bausch Health Companies Shares Are Trading Higher After RBC Capital Raised Its Price Target on the Stock From $10 to $11.
RBC on Bausch Health's Q3
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Bausch Health Companies Analyst Ratings
A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $3 to $12
RBC Lifts Price Target on Bausch Health to $11 From $10, Keeps Sector Perform Rating
Bausch Health Options Spot-On: On October 31st, 86,196 Contracts Were Traded, With 303.29K Open Interest
On October 31st ET, $Bausch Health(BHC.US)$ had active options trading, with a total trading volume of 86,196 options for the day, of which put options accounted for 79.56% of the total transactions,
Bausch Health | 10-Q: Q3 2024 Earnings Report
Toronto Stocks Drop, Canada's GDP Flat in August; Bausch Health Rises on 3Q Beat
Piper Sandler Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $3
Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript Summary
Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates
Bausch Health Raises 2024 Revenue Guidance
Bausch Health Companies GAAP EPS of -$0.23 Misses by $0.37, Revenue of $2.51B Beats by $90M
Bausch Health up 5.5% in New York Trade as It Reports a Higher Adjusted Third-Quarter Profit, Ups Guidance